Ophthalmology and Therapy
Published by Springer Nature
ISSN : 2193-8245 eISSN : 2193-6528
Abbreviation : Ophthalmol. Ther.
Aims & Scope
Ophthalmology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal.
The scope of the journal is broad and will consider all scientifically sound research from preclinical, clinical (all phases), observational, real-world, and health outcomes research around the use of ophthalmological therapies, devices, and surgical techniques.
The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials.
Ophthalmology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data.
Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations.
This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 3.2 |
| 2024 | 2.60 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 1.187 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q1 |
h-index
| Year | Value |
|---|---|
| 2024 | 42 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 3623 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 1657 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 4,700.00 GBP. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Digital Eye Strain- A Comprehensive Review
Citation: 159
Authors: Kirandeep, Bharat, Swatishree, Nilutparna, Savleen, Jitendra, Digvijay, Sumita, Jameel Rizwana, Jaspreet, Deepak
-
Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study
Citation: 132
Authors: Asim V., Simona, Rakesh, Praneetha, Sagar, Ajay K., Andrzej, Douglas, Brian E., Ashraf Z., Bennie H., Natalie S., Joanna, January, Trisha, Julie, Ira, Kathryn
-
Face Mask-Associated Ocular Irritation and Dryness
Citation: 127
Authors: Majid, William B., Douglas P.
-
Systematic Literature Review of Clinical and Economic Outcomes of Micro-Invasive Glaucoma Surgery (MIGS) in Primary Open-Angle Glaucoma
Citation: 110
Authors: Pavi, Steven E.
-
Blue Light Exposure: Ocular Hazards and Prevention—A Narrative Review
Citation: 104
Authors: Audrey, Bénédicte M. J., Tariq, Johanna M., Isabelle, Caroline C. W., Gerhard, Alfredo Garcia, Angelo Maria, Rufino, Cécile
-
The Use of ChatGPT to Assist in Diagnosing Glaucoma Based on Clinical Case Reports
Citation: 104
Authors: Mohammad, Hina, Yeganeh, Anthony A., Barbara M., Malik Y., Siamak
-
Intraocular Pressure Effects of Common Topical Steroids for Post-Cataract Inflammation: Are They All the Same?
Citation: 100
Authors: Uwe, Paul G., Paolo
-
Advances in Retinal Imaging and Applications in Diabetic Retinopathy Screening: A Review
Citation: 99
Authors: Beau J., Raymond L. M., Wai-Ching, Gavin S. W., Gemmy C. M.
-
Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape
Citation: 94
Authors: John D., Kelly K.
-
Optical Coherence Tomography-Based Deep-Learning Models for Classifying Normal and Age-Related Macular Degeneration and Exudative and Non-Exudative Age-Related Macular Degeneration Changes
Citation: 94
Authors: Naohiro, Guangzhou, Seiji, Shohei, Michiko, Yasuhiko, Hideo, Masahiro, Akitaka, Masayo, Yasuo